Premium
Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus‐related cirrhosis
Author(s) -
Wang JingHoung,
Chuah SengKee,
Lu ShengNan,
Hung ChaoHung,
Chen ChienHung,
Kee KwongMing,
Chang KuoChin,
Tai WeiChen,
Hu TsungHui
Publication year - 2012
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2012.07132.x
Subject(s) - medicine , transient elastography , cirrhosis , gastroenterology , esophageal varices , varices , hepatitis b virus , superinfection , portal hypertension , virus , immunology , liver fibrosis
Background and Aim: Transient elastography (TE) has been useful in esophageal varices (EV) diagnosis for chronic hepatitis C patients. In the present study, we evaluate the usefulness of TE and simple blood markers in the EV diagnosis of patients with hepatitis B virus (HBV)‐related cirrhosis, prospectively. Methods: Consecutive patients with compensated cirrhosis and positive HBV surface antigen were enrolled, prospectively. At enrollment, the aspartate aminotransferase (AST) to alanine aminotransferase ratio (AAR) and the AST to platelet ratio index (APRI) were recorded, and TE was performed. Two experienced endoscopists assessed EV independently. High‐risk EV was defined as small size with a red color sign, and medium or large in size. The diagnostic performances, optimal cut‐offs, and the validities of TE, APRI, platelet count (PLT), and AAR in EV diagnosis were assessed. Results: A total of 126 patients (male/female: 93/33; mean age: 54.5 years) with reliable TE results were analyzed. There was good agreement between two endoscopists in assessing the presence of EV and high‐risk EV (kappa value: 0.82 and 0.96). Forty‐eight (38.1%) patients had EV (small: 35; high risk: 13). There was correlation between TE result and EV size (r = 0.515, P < 0.001). TE, APRI, and PLT were similar; however, superior to AAR in the diagnostic accuracies for EV and high‐risk EV. In high‐risk EV prediction, the negative predictive value (NPV) was 97%, 98%, and 98%, with cut‐offs of 21 kPa, 1.24, and 110 (× 10 9 /L) for TE, APRI, and PLT, respectively. Conclusions: For compensated patients with HBV‐related cirrhosis, TE, APRI, and PLT are useful in excluding high‐risk EV with high NPV.